What is Sweet Syndrome

Sweet Syndrome, also known as acute febrile neutrophilic dermatosis, is a rare inflammatory condition characterized by the sudden onset of fever and painful, red, raised skin lesions. It occurs when a specific type of white blood cell, the neutrophil, accumulates in the upper layers of the skin, often as a reaction to an underlying infection, medication, or malignancy.

What are the symptoms and body systems affected by Sweet Syndrome?

The hallmark of Sweet Syndrome is the appearance of tender, erythematous plaques or nodules, typically on the arms, neck, face, and back. While the skin is the primary site of involvement, Sweet Syndrome can also affect other organs, including the eyes, lungs, kidneys, and joints. Patients frequently experience systemic symptoms such as high fever, malaise, and extreme fatigue.

What are the classifications of Sweet Syndrome?

Medical experts categorize Sweet Syndrome into three distinct clinical forms based on the trigger or association:

• Classical Sweet Syndrome: Often follows an upper respiratory infection or gastrointestinal illness; it is frequently seen in women aged 30–50.


• Malignancy-associated Sweet Syndrome: Occurs in roughly 10–20% of cases and is linked to underlying blood cancers, most commonly acute myeloid leukemia.


• Drug-induced Sweet Syndrome: Triggered by specific medications, such as certain antibiotics or granulocyte colony-stimulating factor (G-CSF).

Who is typically affected by Sweet Syndrome?

Sweet Syndrome is considered a rare condition with no exact global prevalence, though it is most frequently diagnosed in women between the ages of 30 and 60. While it can occur at any age, the female-to-male ratio is approximately 4:1. Currently, 73 people with Sweet Syndrome have joined the DiseaseMaps community to share their lived experiences and clinical journeys.

How does Sweet Syndrome differ from other conditions?

Unlike common skin rashes, Sweet Syndrome is a systemic inflammatory process. It is clinically distinct from conditions like cellulitis because the lesions are sterile (containing no bacteria) and respond rapidly to systemic corticosteroids, which are the gold-standard treatment for Sweet Syndrome.

Next steps

• Consult a board-certified dermatologist or rheumatologist for a skin biopsy to confirm the diagnosis.


• Undergo blood work to rule out associated underlying conditions, such as hematologic malignancies.


• Connect with the 73 community members on DiseaseMaps.org to share support and management strategies.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Sweet Syndrome Overview.


• Orphanet: Acute febrile neutrophilic dermatosis (ORPHA:3197).


• PubMed/NCBI: Diagnostic criteria and management of neutrophilic dermatoses.


• American Academy of Dermatology (AAD): Patient resource on neutrophilic conditions.